摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-戊基吡啶 | 1802-20-6

中文名称
3-戊基吡啶
中文别名
——
英文名称
3-pentyl-pyridine
英文别名
3-Pentyl-pyridin;1-(3-pyridyl)pentane;3-Pentylpyridine
3-戊基吡啶化学式
CAS
1802-20-6
化学式
C10H15N
mdl
——
分子量
149.236
InChiKey
WPFPTAWUHHGUDQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • LogP:
    3.378 (est)
  • 保留指数:
    1242

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    11
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    12.9
  • 氢给体数:
    0
  • 氢受体数:
    1

安全信息

  • 海关编码:
    2933399090
  • 危险性防范说明:
    P261,P280,P301+P312,P302+P352,P305+P351+P338
  • 危险性描述:
    H302,H315,H320,H335
  • 储存条件:
    室温下保存于惰性气体中

SDS

SDS:22f33564e2d887dba8f501ea44e1772f
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-戊基吡啶copper(l) iodide四(三苯基膦)钯 氢氧化钾copper(l) iodide正丁基锂三乙胺 作用下, 以 甲醇正己烷二氯甲烷N,N-二甲基甲酰胺 为溶剂, 生成 3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(5-pentylpyridin-2-yl)furo[2,3-d]pyrimidin-2-one
    参考文献:
    名称:
    Synthesis and Antiviral Evaluation of 6-(Alkyl-heteroaryl)furo[2,3-d]pyrimidin-2(3H)-one Nucleosides and Analogues with Ethynyl, Ethenyl, and Ethyl Spacers at C6 of the Furopyrimidine Core
    摘要:
    Sonogashira coupling strategies were employed to synthesize new furo[2,3-d]pyrimidin-2(3H)-one (FuPyrm) 2'-deoxynucleoside analogues. Partial or complete reduction of ethyne-linked compounds afforded ethenyl-and ethyl-linked derivatives. Levels of inhibition of varicella-zoster virus (VZV), human cytomegalovirus (HCMV), a broad range of other DNA and RNA viruses, and several cancer cell lines were evaluated in cell cultures. The anti-VZV potency decreased with increasing rigidity of the side chain at C6 of the FuPyrm ring in the order dec-1-yn-1-yl < dec-1-en-1-yl < decan-1-yl. In contrast, compounds with a rigid ethynyl spacer between C6 of the FuPyrm ring and a 4-alkylphenyl moiety were more potent inhibitors of VZV than the corresponding derivatives with an ethyl spacer. Replacement of the phenyl moiety in 6-(4-alkylphenyl) derivatives with a pyridine ring (in either regioisomeric orientation) gave analogues with increased solubility in methanol but reduced anti-VZV potency, and replacement with a pyrimidine ring reduced the anti-VZV activity even further. The pyridine-ring-containing analogues were similar to 20-fold more potent inhibitors of VZV than acyclovir but were similar to 6-fold less potent than BVDU and similar to 60-fold weaker than the most active 6-(4-pentylphenyl) -substituted prototype.
    DOI:
    10.1021/jm070210n
  • 作为产物:
    描述:
    正溴丁烷正丁基锂二异丙胺氯化铵 作用下, 以 四氢呋喃乙醚 为溶剂, 反应 1.5h, 以46%的产率得到3-戊基吡啶
    参考文献:
    名称:
    WO2007/128059
    摘要:
    公开号:
点击查看最新优质反应信息

文献信息

  • Practical and Selective sp <sup>3</sup> C−H Bond Chlorination via Aminium Radicals
    作者:Alastair J. McMillan、Martyna Sieńkowska、Piero Di Lorenzo、Gemma K. Gransbury、Nicholas F. Chilton、Michela Salamone、Alessandro Ruffoni、Massimo Bietti、Daniele Leonori
    DOI:10.1002/anie.202100030
    日期:2021.3.22
    also the fine‐tuning of physicochemical and biological properties of drugs, agrochemicals and polymers. We report here a general and practical photochemical strategy enabling the site‐selective chlorination of sp3 C−H bonds. This process exploits the ability of protonated N‐chloroamines to serve as aminium radical precursors and also radical chlorinating agents. Upon photochemical initiation, an efficient
    原子引入有机分子对于工业化学品的制造、先进合成中间体的精制以及药物、农用化学品和聚合物的物理化学生物特性的微调至关重要。我们在这里报告了一种通用且实用的光化学策略,能够实现 sp 3 C−H 键的位点选择性化。该过程利用了质子化的N-氯胺作为自由基前体和自由基化剂的能力。在光化学引发后,建立了有效的自由基链传播,由于存在大量兼容的官能团,因此允许多种底物的官能化。通过适当选择基,能够协同最大化 H 原子转移过渡态中的极性和空间效应,为自由基 sp 3 C−H 化提供了已知的最高选择性。
  • [EN] 2- [ (2-{PHENYLAMINO}-1H-PYRROLO [2, 3-D] PYRIMIDIN-4-YL) AMINO] BENZAMIDE DERIVATIVES AS IGF-1R INHIBITORS FOR THE TREATMENT OF CANCER<br/>[FR] DÉRIVÉS DE 2-[(2-{PHÉNYLAMINO}-1H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]BENZAMIDE EN TANT QU'INHIBITEUR D'IGF-1R POUR LE TRAITEMENT DU CANCER
    申请人:SMITHKLINE BEECHAM CORP
    公开号:WO2009020990A1
    公开(公告)日:2009-02-12
    Novel pyrrolopyrimidines as shown in formula (I) and pharmaceutically acceptable derivatives thereof. The compounds are useful in the inhibition of IGF-1R.
    新型吡咯嘧啶如公式(I)所示,及其药用可接受的衍生物。这些化合物在抑制IGF-1R方面是有用的。
  • METHOD AND SUBSTANCES FOR PREPARATION OF N-SUBSTITUTED PYRIDINIUM COMPOUNDS
    申请人:Gebauer Peter
    公开号:US20130303768A1
    公开(公告)日:2013-11-14
    A method for the synthesis of N-substituted 3-acylated pyridinium compounds by reacting a pentamethine precursor with a primary amine.
    一种通过将五甲基前体物与一级胺反应合成N-取代3-酰基吡啶化合物的方法。
  • PROCESS FOR PRODUCTION OF BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE
    申请人:Okamoto Kuniaki
    公开号:US20120130107A1
    公开(公告)日:2012-05-24
    Object To provide a method for producing a bis-quaternary ammonium salt efficiently and a novel synthetic intermediate thereof. Solution The present invention relates to a method for producing a bis-quaternary ammonium salt represented by a general formula [3] which comprises reacting a disulfonic acid ester represented by a general formula [1] (in the formula, definitions of two R 1 's and T are as described in claim 1 ) with a tertiary amine represented by a general formula [2] (in the formula, definitions of R 3 to R 5 are as described in claim 1 ), and a disulfonic acid ester represented by a general formula [1′] (in the formula, two R 16 's represent independently a halogen atom or a C1-C3 fluoroalkyl group, and two m's represent independently an integer of 1 to 5).
    提供一种高效生产双季盐和其新型合成中间体的方法。本发明涉及一种生产由通用式[3]表示的双季盐的方法,包括将由通用式[1]表示的二磺酸酯(在该式中,两个R1和T的定义如权利要求1中所述)与由通用式[2]表示的三级胺(在该式中,R3到R5的定义如权利要求1中所述)以及由通用式[1']表示的二磺酸酯(在该式中,两个R16独立表示卤原子或C1-C3氟烷基,两个m独立表示1至5的整数)反应。
  • IONIC LIQUID CONTAINING ALLYLSULFONATE ANION
    申请人:Watahiki Tsutomu
    公开号:US20120157680A1
    公开(公告)日:2012-06-21
    PROBLEM: Providing a novel ionic liquid, which is low-cost, environment-friendly, and has low viscosity and melting point. MEANS FOR SOLVING THE PROBLEM: The present invention is the invention of the ionic liquid represented by the general formula [1]: wherein, R 1 to R 3 and n pieces of R 4 each independently represent hydrogen atom or alkyl group having 1 to 4 carbon atoms, R 5 to R 7 each independently represent alkyl group, aralkyl group, or aryl group, R 8 represents alkyl group, aralkyl group, aryl group, or the one represented by the general formula [2]: (wherein T represents alkylene chain having 1 to 8 carbon atoms, n represents 1 or 2, and R 1 to R 7 are the same as the above-described), X represents nitrogen atom or phosphorus atom, n represents 1 or 2. When n is 1, R 3 and R 4 are bound and may form cyclohexene ring together with the adjacent carbon atoms. In addition, when X is nitrogen atom, R 5 to R 7 or R 5 to R 6 may form hetero ring with nitrogen atom binding thereto}.
    问题:提供一种新型离子液体,成本低、环保,并具有低粘度和熔点。 解决问题的方法:本发明是一种由通式[1]表示的离子液体的发明:其中,R1到R3和n个R4分别独立表示氢原子或具有1到4个碳原子的烷基基团,R5到R7分别独立表示烷基基团、芳基烷基基团或芳基基团,R8表示烷基基团、芳基烷基基团、芳基基团或由通式[2]表示的基团:(其中T表示具有1到8个碳原子的烷基链,n表示1或2,R1到R7与上述相同),X表示氮原子或原子,n表示1或2。当n为1时,R3和R4结合并且可能与相邻碳原子一起形成环己烯环。此外,当X为氮原子时,R5到R7或R5到R6可能与结合在一起的氮原子形成杂环}。
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S,2'S)-(-)-[N,N'-双(2-吡啶基甲基]-2,2'-联吡咯烷双(乙腈)铁(II)六氟锑酸盐 (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 (1'R,2'S)-尼古丁1,1'-Di-N-氧化物 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸氯苯那敏-D6 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 韦德伊斯试剂 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非布索坦杂质66 非尼拉朵 非尼拉敏 雷索替丁 阿雷地平 阿瑞洛莫 阿扎那韦中间体 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 镉,二碘四(4-甲基吡啶)- 锌,二溴二[4-吡啶羧硫代酸(2-吡啶基亚甲基)酰肼]-